About Medico Intercontinental Limited
Data last updated: 25 June 2026
Medico Intercontinental Limited is a public limited company based in Ahmedabad, Gujarat, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 14 August 1984, the company has been in operation for over 42 years.
Registered with ROC Ahmedabad under CIN L24100GJ1984PLC111413. Listed on BSE: 539938.
Capital: an authorised share capital of ₹20 Cr and a paid-up capital of ₹10 Cr. Formerly known as Medico Mediserve India Limited and Medico Mediserve Trading Limited. It is led by directors including Samir Dilipkumar Shah and Dilipkumar Shah Bhogilal.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹96.37 Cr, a growth of 34% compared to the previous year.
The company has a workforce of approximately 17 employees as per the latest available data. Its group structure includes 4 subsidiaries.
The company is associated with 1 brand - Medico Intercontinental. As per MCA filings, the company has open charges of ₹15.5 Cr and satisfied charges of ₹2.05 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medicointercontinental.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered Address1 – 5Th Floor Adit Raj Arcade Nr Karma Shreshtha Tower 100 Ft Rd Sat, Ellite, Ahmedabad, Gujarat, India – 380015
-
IndustryPharma, Pharmaceutical Retailers & Distributors
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Medico Intercontinental Limited
Medico Intercontinental Limited has undergone 3 name changes throughout its history. The company was previously known as Medico Mediserve India Limited, Medico Mediserve Trading Limited, and Intercontinental Leasing And Finance Company Limited. The current legal name is Medico Intercontinental Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Medico Intercontinental Limited | Current |
| Medico Mediserve India Limited | Previous |
| Medico Mediserve Trading Limited | Previous |
| Intercontinental Leasing And Finance Company Limited | Previous |
CIN History of Medico Intercontinental Limited
Medico Intercontinental Limited has 5 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24100GJ1984PLC111413, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24100GJ1984PLC111413 | Current |
| L24100MH1984PLC269707 | Previous |
| L67120DL1984PLC018974 | Previous |
| U67120DL1984PLC018974 | Previous |
| L67120MH1984PLC269707 | Previous |
| L51100MH1984PLC269707 | Previous |
Associated Brands with Medico Intercontinental Limited
Medico Intercontinental Limited operates one associated brand: Medico Intercontinental. These brands represent Medico Intercontinental Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Biopharmaceuticals, health devices, and therapies in healthcare sectors. | medicointercontinental.com |
Business Activity of Medico Intercontinental Limited
Medico Intercontinental Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | ********* |
Auditor Details of Medico Intercontinental Limited
Medico Intercontinental Limited is audited by V GOSWAMI & CO (ICAI peer reviewed, certificate valid till 2028-09-30) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| V GOSWAMI & CO (ICAI peer reviewed, certificate valid till 2028-09-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Medico Intercontinental Limited
Medico Intercontinental Limited is currently managed by 10 directors, with 25 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Samir Dilipkumar Shah
Also directs:
Azillian Healthcare Private Limited, Kings Marvela Llp, Ritz Formulations Private Limited and 5 more
|
Managing Director | 14 Aug 2018 | 7 Years 10 Months | Current |
|
Dilipkumar Shah Bhogilal
Also directs:
Azillian Healthcare Private Limited, Kings Marvela Llp, Ritz Formulations Private Limited and 3 more
|
Ceo | 29 May 2019 | 7 Years 1 Months | Current |
|
Ankur Amiram Dave
Also directs:
Azillian Healthcare Private Limited
|
Director | 23 Mar 2019 | 7 Years 3 Months | Current |
| Swati Vikramkumar Shah | Director | 29 May 2019 | 7 Years 1 Months | Current |
| Priyank Lalitbhai Sancheti | Director | 14 Nov 2022 | 3 Years 7 Months | Current |
| Parshwa Kaushal Shah | Director | 10 May 2024 | 2 Years 1 Months | Current |
Financials of Medico Intercontinental Limited FY 2026 filings available
Medico Intercontinental Limited reported revenue of ₹84.08 Cr (down 12.43% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹84.08 Cr | ₹96.02 Cr | ₹71.36 Cr | ₹76.23 Cr | ₹74.26 Cr | ₹69.74 Cr | ₹81.96 Cr | ₹10.3 Cr |
| Other Income | ₹1.27 Cr | ₹35.6 Lakh | ₹40.14 Lakh | ₹51.2 Lakh | ₹30.62 Lakh | ₹17.84 Lakh | ₹5.12 Lakh | ₹52,000 |
| Total Income | ₹85.35 Cr | ₹96.37 Cr | ₹71.76 Cr | ₹76.74 Cr | ₹74.57 Cr | ₹69.92 Cr | ₹82.01 Cr | ₹10.31 Cr |
| Cost of Materials Consumed | ₹7.7 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹53.97 Cr | ₹73.41 Cr | ₹56.43 Cr | ₹63.3 Cr | ₹59.61 Cr | ₹58.05 Cr | ₹75.18 Cr | ₹9.53 Cr |
| Changes in Inventories | ₹98.77 Lakh | ₹1.2 Cr | -₹1.56 Cr | -₹99.56 Lakh | ₹1.23 Cr | -₹43.38 Lakh | -₹5.84 Cr | -₹63.15 Lakh |
| Employee Benefit Expense | ₹8.77 Cr | ₹4.75 Cr | ₹3.92 Cr | ₹3.22 Cr | ₹2.31 Cr | ₹2.17 Cr | ₹3.22 Cr | ₹10.64 Lakh |
| Finance Costs | ₹8.16 Cr | ₹99.55 Lakh | ₹49.31 Lakh | ₹61.86 Lakh | ₹87.4 Lakh | ₹1.28 Cr | ₹1.1 Cr | ₹65,000 |
| Depreciation & Amortisation | ₹5.43 Cr | ₹80.83 Lakh | ₹28.67 Lakh | ₹20.34 Lakh | ₹20.5 Lakh | ₹13.74 Lakh | ₹10.5 Lakh | ₹32,000 |
| Other Expenses | ₹9.69 Cr | ₹8.24 Cr | ₹6.76 Cr | ₹5.44 Cr | ₹6.11 Cr | ₹5.18 Cr | ₹5.06 Cr | ₹29.07 Lakh |
| Total Expenses | ₹94.69 Cr | ₹89.4 Cr | ₹66.32 Cr | ₹71.79 Cr | ₹70.34 Cr | ₹66.39 Cr | ₹78.81 Cr | ₹9.3 Cr |
| Profit Before Exceptional Items & Tax | -₹9.34 Cr | ₹6.97 Cr | ₹5.44 Cr | ₹4.94 Cr | ₹4.23 Cr | ₹3.53 Cr | ₹3.2 Cr | ₹1 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹9.34 Cr | ₹6.97 Cr | ₹5.44 Cr | ₹4.94 Cr | ₹4.23 Cr | ₹3.53 Cr | ₹3.2 Cr | ₹1 Cr |
| Total Tax Expense | ₹1.75 Cr | ₹1.92 Cr | ₹1.49 Cr | ₹1.34 Cr | ₹1.13 Cr | ₹95.6 Lakh | ₹84.5 Lakh | ₹26.87 Lakh |
| Net Profit | -₹10.98 Cr | ₹5.06 Cr | ₹3.95 Cr | ₹3.61 Cr | ₹3.1 Cr | ₹2.58 Cr | ₹2.36 Cr | ₹73.6 Lakh |
| attributable to Owners | -₹3.2 Cr | ₹5.06 Cr | ₹3.95 Cr | ₹3.61 Cr | ₹3.1 Cr | ₹2.58 Cr | ₹2.36 Cr | - |
| attributable to NCI | -₹7.78 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹10.98 Cr | ₹5.06 Cr | ₹3.95 Cr | ₹3.61 Cr | ₹3.1 Cr | ₹2.58 Cr | ₹2.36 Cr | ₹73.6 Lakh |
| EBITDA (computed) | ₹4.25 Cr | ₹8.78 Cr | ₹6.22 Cr | ₹5.77 Cr | ₹5.31 Cr | ₹4.95 Cr | ₹4.4 Cr | ₹1.01 Cr |
| Basic EPS | ₹-3.20 | ₹5.06 | ₹3.95 | ₹5.61 | ₹9.54 | ₹7.93 | ₹7.25 | ₹2.27 |
| Diluted EPS | ₹-3.20 | ₹5.06 | ₹3.95 | ₹5.61 | ₹9.54 | ₹7.93 | ₹7.25 | ₹2.27 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹117.26 Cr | ₹75.76 Cr | ₹56.04 Cr | ₹58.88 Cr | ₹31.94 Cr | ₹30.65 Cr | ₹38.84 Cr | ₹9.33 Cr |
| Non-current Assets | ₹56.01 Cr | ₹19.19 Cr | ₹17.56 Cr | ₹9.18 Cr | ₹3.68 Cr | ₹2.52 Cr | ₹4.81 Cr | ₹1.35 Lakh |
| Current Assets | ₹61.25 Cr | ₹56.58 Cr | ₹38.48 Cr | ₹49.7 Cr | ₹28.26 Cr | ₹28.12 Cr | ₹34.02 Cr | ₹9.31 Cr |
| Property, Plant & Equipment | ₹36.83 Cr | ₹3.62 Cr | ₹2.39 Cr | ₹1.44 Cr | ₹1.22 Cr | ₹1.21 Cr | ₹1.14 Cr | ₹19,000 |
| Inventories | ₹14.93 Cr | ₹9.24 Cr | ₹10.44 Cr | ₹8.88 Cr | ₹7.88 Cr | ₹9.11 Cr | ₹8.68 Cr | ₹63.15 Lakh |
| Trade Receivables | ₹27.42 Cr | ₹32.85 Cr | ₹23.21 Cr | ₹32.85 Cr | ₹17.14 Cr | ₹17.98 Cr | ₹22.77 Cr | ₹6.47 Cr |
| Cash & Equivalents | ₹5.96 Cr | ₹2.69 Cr | ₹3.37 Cr | ₹6.79 Cr | ₹1.87 Cr | ₹51.48 Lakh | ₹77.88 Lakh | ₹12.25 Lakh |
| Equity (Net Worth) | ₹32.27 Cr | ₹48.65 Cr | ₹45.03 Cr | ₹41.19 Cr | ₹12.64 Cr | ₹9.54 Cr | ₹9.16 Cr | ₹4 Cr |
| Equity Share Capital | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹3.25 Cr | ₹3.25 Cr | ₹3.25 Cr | ₹3.25 Cr |
| Borrowings (Non-current) | ₹46.09 Cr | ₹13.47 Cr | ₹1.87 Cr | ₹2.22 Cr | ₹6.25 Cr | ₹6.54 Cr | ₹13.08 Cr | ₹11.21 Lakh |
| Borrowings (Current) | ₹21.04 Cr | ₹3.45 Cr | ₹2.98 Cr | ₹2.5 Cr | ₹2.39 Cr | ₹2.42 Cr | ₹8.18 Lakh | ₹0 |
| Total Debt (computed) | ₹67.12 Cr | ₹16.92 Cr | ₹4.85 Cr | ₹4.72 Cr | ₹8.63 Cr | ₹8.96 Cr | ₹13.16 Cr | ₹11.21 Lakh |
| Current Liabilities | ₹37.74 Cr | ₹12.76 Cr | ₹8.99 Cr | ₹15.36 Cr | ₹13.05 Cr | ₹14.54 Cr | ₹16.58 Cr | ₹5.21 Cr |
| Total Liabilities | ₹84.99 Cr | ₹27.12 Cr | ₹11.01 Cr | ₹17.69 Cr | ₹19.31 Cr | ₹21.11 Cr | ₹29.68 Cr | ₹5.32 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹17.08 Cr | -₹7.11 Cr | ₹5.58 Cr | -₹10.1 Cr | ₹3.85 Cr |
| Investing Cash Flow | ₹2.2 Cr | -₹2.19 Cr | -₹8.54 Cr | -₹5.38 Cr | -₹1.3 Cr |
| Financing Cash Flow | -₹15.56 Cr | ₹8.63 Cr | -₹45.79 Lakh | ₹20.41 Cr | -₹1.2 Cr |
| Capital Expenditure | ₹4.64 Cr | ₹2 Cr | ₹1.23 Cr | ₹42.18 Lakh | ₹21.13 Lakh |
| Free Cash Flow (computed) | ₹12.43 Cr | -₹9.11 Cr | ₹4.34 Cr | -₹10.53 Cr | ₹3.64 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹10 Lakh | ₹0 | ₹0 |
| Net Change in Cash | ₹3.72 Cr | -₹67.53 Lakh | -₹3.42 Cr | ₹4.92 Cr | ₹1.35 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹22.49 Cr | ₹19.85 Cr | ₹20.4 Cr | ₹21.35 Cr | ₹21.39 Cr | ₹19.15 Cr | ₹37.24 Cr | ₹18.23 Cr |
| Other Income | ₹11.16 Lakh | ₹34.17 Lakh | ₹55.41 Lakh | ₹26.3 Lakh | ₹8 Lakh | ₹10.8 Lakh | ₹4.1 Lakh | ₹12.7 Lakh |
| Total Income | ₹22.6 Cr | ₹20.19 Cr | ₹20.95 Cr | ₹21.62 Cr | ₹21.47 Cr | ₹19.26 Cr | ₹37.28 Cr | ₹18.36 Cr |
| Cost of Materials Consumed | ₹2.35 Cr | ₹1.31 Cr | ₹2.42 Cr | ₹1.61 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹12.93 Cr | ₹15.29 Cr | ₹12.87 Cr | ₹12.89 Cr | ₹18.32 Cr | ₹15.07 Cr | ₹26.54 Cr | ₹13.47 Cr |
| Changes in Inventories | ₹18.44 Lakh | -₹2.25 Cr | ₹1.46 Cr | ₹1.59 Cr | -₹1.41 Cr | -₹48.8 Lakh | ₹2.32 Cr | ₹77.9 Lakh |
| Employee Benefit Expense | ₹2.25 Cr | ₹2.37 Cr | ₹2.19 Cr | ₹1.96 Cr | ₹1.45 Cr | ₹1.27 Cr | ₹1.11 Cr | ₹92.45 Lakh |
| Finance Costs | ₹1.85 Cr | ₹1.9 Cr | ₹2.06 Cr | ₹2.36 Cr | ₹27.44 Lakh | ₹26.18 Lakh | ₹28.3 Lakh | ₹17.62 Lakh |
| Depreciation & Amortisation | ₹1.43 Cr | ₹1.43 Cr | ₹1.95 Cr | ₹61.87 Lakh | ₹28.31 Lakh | ₹23.55 Lakh | ₹20.74 Lakh | ₹8.23 Lakh |
| Other Expenses | ₹3.16 Cr | ₹1.54 Cr | ₹2.34 Cr | ₹2.64 Cr | ₹1.03 Cr | ₹1.29 Cr | ₹4.48 Cr | ₹1.44 Cr |
| Total Expenses | ₹24.15 Cr | ₹21.59 Cr | ₹25.29 Cr | ₹23.66 Cr | ₹19.95 Cr | ₹17.64 Cr | ₹34.94 Cr | ₹16.87 Cr |
| Profit Before Exceptional Items & Tax | -₹1.55 Cr | -₹1.4 Cr | -₹4.35 Cr | -₹2.04 Cr | ₹1.52 Cr | ₹1.62 Cr | ₹2.34 Cr | ₹1.49 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹1.55 Cr | -₹1.4 Cr | -₹4.35 Cr | -₹2.04 Cr | ₹1.52 Cr | ₹1.62 Cr | ₹2.34 Cr | ₹1.49 Cr |
| Total Tax Expense | ₹79.83 Lakh | ₹28.4 Lakh | ₹19.34 Lakh | ₹47.49 Lakh | ₹35.55 Lakh | ₹44.83 Lakh | ₹70.53 Lakh | ₹40.69 Lakh |
| Net Profit | -₹2.33 Cr | -₹1.65 Cr | -₹4.51 Cr | -₹2.49 Cr | ₹1.17 Cr | ₹1.17 Cr | ₹1.63 Cr | ₹1.08 Cr |
| attributable to Owners | -₹65.31 Lakh | -₹21.78 Lakh | -₹1.65 Cr | -₹67.82 Lakh | ₹1.17 Cr | ₹1.17 Cr | ₹1.63 Cr | ₹1.08 Cr |
| attributable to NCI | -₹1.68 Cr | -₹1.44 Cr | -₹2.86 Cr | -₹1.81 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹2.33 Cr | -₹1.65 Cr | -₹4.51 Cr | -₹2.49 Cr | ₹1.17 Cr | ₹1.17 Cr | ₹1.63 Cr | ₹1.08 Cr |
| EBITDA (computed) | ₹1.72 Cr | ₹1.93 Cr | -₹33.36 Lakh | ₹93.45 Lakh | ₹2.08 Cr | ₹2.12 Cr | ₹2.83 Cr | ₹1.75 Cr |
| Basic EPS | ₹-0.65 | ₹-0.22 | ₹-1.65 | ₹-0.68 | ₹1.17 | ₹1.17 | ₹1.63 | ₹1.08 |
| Diluted EPS | ₹-0.65 | ₹-0.22 | ₹-1.65 | ₹-0.68 | ₹1.17 | ₹1.17 | ₹1.63 | ₹1.08 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹54.46 Cr | ₹67.13 Cr | ₹44.04 Cr | ₹48.88 Cr | ₹39.25 Cr | ₹41.02 Cr | ₹46.93 Cr | ₹10.3 Cr |
| Other Income | ₹2.35 Cr | ₹50.77 Lakh | ₹41.66 Lakh | ₹34.32 Lakh | ₹17.84 Lakh | ₹16.43 Lakh | ₹2.44 Lakh | ₹52,000 |
| Total Income | ₹56.81 Cr | ₹67.64 Cr | ₹44.45 Cr | ₹49.23 Cr | ₹39.43 Cr | ₹41.19 Cr | ₹46.96 Cr | ₹10.31 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹44.86 Cr | ₹54.45 Cr | ₹37.46 Cr | ₹43.34 Cr | ₹32.97 Cr | ₹36.78 Cr | ₹43.87 Cr | ₹9.53 Cr |
| Changes in Inventories | ₹82.69 Lakh | ₹1.63 Cr | -₹88.16 Lakh | -₹1.22 Cr | ₹1.09 Cr | -₹99.79 Lakh | -₹1.93 Cr | -₹63.15 Lakh |
| Employee Benefit Expense | ₹2.46 Cr | ₹1.74 Cr | ₹1.59 Cr | ₹1.2 Cr | ₹1.03 Cr | ₹85.81 Lakh | ₹98.59 Lakh | ₹10.64 Lakh |
| Finance Costs | ₹1.67 Cr | ₹67.22 Lakh | ₹22.29 Lakh | ₹36.77 Lakh | ₹52.14 Lakh | ₹77.91 Lakh | ₹65.51 Lakh | ₹65,000 |
| Depreciation & Amortisation | ₹69.35 Lakh | ₹55.57 Lakh | ₹17.83 Lakh | ₹8.66 Lakh | ₹10.44 Lakh | ₹6.26 Lakh | ₹2.45 Lakh | ₹32,000 |
| Other Expenses | ₹3.18 Cr | ₹5.02 Cr | ₹3.26 Cr | ₹3.08 Cr | ₹1.88 Cr | ₹2.04 Cr | ₹1.81 Cr | ₹26.76 Lakh |
| Total Expenses | ₹53.69 Cr | ₹64.06 Cr | ₹41.83 Cr | ₹46.85 Cr | ₹37.6 Cr | ₹39.53 Cr | ₹45.42 Cr | ₹9.28 Cr |
| Profit Before Exceptional Items & Tax | ₹3.12 Cr | ₹3.58 Cr | ₹2.62 Cr | ₹2.38 Cr | ₹1.83 Cr | ₹1.66 Cr | ₹1.54 Cr | ₹1.03 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹3.12 Cr | ₹3.58 Cr | ₹2.62 Cr | ₹2.38 Cr | ₹1.83 Cr | ₹1.66 Cr | ₹1.54 Cr | ₹1.03 Cr |
| Total Tax Expense | ₹93.28 Lakh | ₹1.01 Cr | ₹72.74 Lakh | ₹67.42 Lakh | ₹51.6 Lakh | ₹46.51 Lakh | ₹41.78 Lakh | ₹26.87 Lakh |
| Net Profit | ₹2.18 Cr | ₹2.57 Cr | ₹1.9 Cr | ₹1.7 Cr | ₹1.31 Cr | ₹1.2 Cr | ₹1.12 Cr | ₹75.91 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹2.18 Cr | ₹2.57 Cr | ₹1.9 Cr | ₹1.7 Cr | ₹1.31 Cr | ₹1.2 Cr | ₹1.12 Cr | ₹75.91 Lakh |
| EBITDA (computed) | ₹5.48 Cr | ₹4.8 Cr | ₹3.03 Cr | ₹2.83 Cr | ₹2.45 Cr | ₹2.5 Cr | ₹2.22 Cr | ₹1.04 Cr |
| Basic EPS | ₹2.18 | ₹2.57 | ₹1.90 | ₹2.65 | ₹4.04 | ₹3.68 | ₹3.44 | ₹2.34 |
| Diluted EPS | ₹2.18 | ₹2.57 | ₹1.90 | ₹2.65 | ₹4.04 | ₹3.68 | ₹3.44 | ₹2.34 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹67.42 Cr | ₹58.77 Cr | ₹39.44 Cr | ₹44.38 Cr | ₹17.72 Cr | ₹16.42 Cr | ₹19.17 Cr | ₹9.32 Cr |
| Non-current Assets | ₹40.26 Cr | ₹21.89 Cr | ₹17.43 Cr | ₹10.63 Cr | ₹5.38 Cr | ₹4.61 Cr | ₹3.7 Cr | ₹4.35 Lakh |
| Current Assets | ₹27.16 Cr | ₹36.88 Cr | ₹22.02 Cr | ₹33.75 Cr | ₹12.34 Cr | ₹11.81 Cr | ₹15.47 Cr | ₹9.28 Cr |
| Property, Plant & Equipment | ₹1.52 Cr | ₹1.68 Cr | ₹33.11 Lakh | ₹47.64 Lakh | ₹19.62 Lakh | ₹24.03 Lakh | ₹11.82 Lakh | ₹19,000 |
| Inventories | ₹2.11 Cr | ₹2.94 Cr | ₹4.57 Cr | ₹3.69 Cr | ₹2.47 Cr | ₹3.56 Cr | ₹2.56 Cr | ₹63.15 Lakh |
| Trade Receivables | ₹17.93 Cr | ₹22.77 Cr | ₹14.93 Cr | ₹24.92 Cr | ₹8.48 Cr | ₹8.03 Cr | ₹12.67 Cr | ₹6.47 Cr |
| Cash & Equivalents | ₹2.16 Cr | ₹1.42 Cr | ₹2.41 Cr | ₹4.95 Cr | ₹1.29 Cr | ₹11.58 Lakh | ₹13.79 Lakh | ₹9.12 Lakh |
| Equity (Net Worth) | ₹40.85 Cr | ₹38.66 Cr | ₹36.1 Cr | ₹34.3 Cr | ₹7.65 Cr | ₹6.34 Cr | ₹5.15 Cr | ₹4.03 Cr |
| Equity Share Capital | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹3.25 Cr | ₹3.25 Cr | ₹3.25 Cr | ₹3.25 Cr |
| Borrowings (Non-current) | ₹14.97 Cr | ₹12.77 Cr | ₹79.79 Lakh | ₹1.94 Cr | ₹5.86 Cr | ₹4.78 Cr | ₹8.52 Cr | ₹9.32 Lakh |
| Borrowings (Current) | ₹1.18 Cr | ₹44.53 Lakh | ₹16.67 Lakh | ₹33.33 Lakh | ₹35.08 Lakh | ₹3.24 Lakh | ₹2.94 Lakh | ₹0 |
| Total Debt (computed) | ₹16.15 Cr | ₹13.22 Cr | ₹96.46 Lakh | ₹2.27 Cr | ₹6.21 Cr | ₹4.82 Cr | ₹8.55 Cr | ₹9.32 Lakh |
| Current Liabilities | ₹11.46 Cr | ₹6.95 Cr | ₹2.48 Cr | ₹8.09 Cr | ₹4.21 Cr | ₹5.3 Cr | ₹5.5 Cr | ₹5.2 Cr |
| Total Liabilities | ₹26.57 Cr | ₹20.11 Cr | ₹3.35 Cr | ₹10.08 Cr | ₹10.06 Cr | ₹10.08 Cr | ₹14.03 Cr | ₹5.29 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹15.43 Cr | -₹6.78 Cr | ₹5.73 Cr | -₹11.95 Cr | ₹1.1 Cr |
| Investing Cash Flow | ₹8.25 Cr | -₹4.78 Cr | -₹6.65 Cr | -₹5.02 Cr | -₹79.9 Lakh |
| Financing Cash Flow | -₹22.94 Cr | ₹10.57 Cr | -₹1.63 Cr | ₹20.63 Cr | ₹87.15 Lakh |
| Capital Expenditure | ₹41.44 Lakh | ₹1.88 Cr | ₹3.3 Lakh | ₹36.68 Lakh | ₹6.03 Lakh |
| Free Cash Flow (computed) | ₹15.02 Cr | -₹8.66 Cr | ₹5.7 Cr | -₹12.32 Cr | ₹1.04 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹10 Lakh | ₹0 | ₹0 |
| Net Change in Cash | ₹74.23 Lakh | -₹98.77 Lakh | -₹2.54 Cr | ₹3.66 Cr | ₹1.17 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹15.82 Cr | ₹12.75 Cr | ₹12.42 Cr | ₹13.47 Cr | ₹15.24 Cr | ₹11.43 Cr | ₹28.94 Cr | ₹11.52 Cr |
| Other Income | ₹72.97 Lakh | ₹79.32 Lakh | ₹58.05 Lakh | ₹24.18 Lakh | ₹13.29 Lakh | ₹17.37 Lakh | ₹9.79 Lakh | ₹10.33 Lakh |
| Total Income | ₹16.55 Cr | ₹13.54 Cr | ₹13 Cr | ₹13.71 Cr | ₹15.38 Cr | ₹11.6 Cr | ₹29.04 Cr | ₹11.62 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹13.07 Cr | ₹12.02 Cr | ₹10.3 Cr | ₹9.48 Cr | ₹13.97 Cr | ₹9.62 Cr | ₹21.36 Cr | ₹9.5 Cr |
| Changes in Inventories | ₹38.18 Lakh | -₹96.97 Lakh | ₹12.96 Lakh | ₹1.29 Cr | -₹81.11 Lakh | -₹16.5 Lakh | ₹2.12 Cr | ₹48.02 Lakh |
| Employee Benefit Expense | ₹66.18 Lakh | ₹72.85 Lakh | ₹56.13 Lakh | ₹50.88 Lakh | ₹53.69 Lakh | ₹45.41 Lakh | ₹37.45 Lakh | ₹37.51 Lakh |
| Finance Costs | ₹39.87 Lakh | ₹38.53 Lakh | ₹44.9 Lakh | ₹43.52 Lakh | ₹23.1 Lakh | ₹16.75 Lakh | ₹17.88 Lakh | ₹9.49 Lakh |
| Depreciation & Amortisation | ₹15.83 Lakh | ₹17.25 Lakh | ₹18.71 Lakh | ₹17.56 Lakh | ₹20.73 Lakh | ₹17.29 Lakh | ₹14.74 Lakh | ₹2.81 Lakh |
| Other Expenses | ₹1.15 Cr | ₹36.73 Lakh | ₹56.98 Lakh | ₹1.09 Cr | ₹54.62 Lakh | ₹60.25 Lakh | ₹3.4 Cr | ₹46.46 Lakh |
| Total Expenses | ₹15.82 Cr | ₹12.7 Cr | ₹12.19 Cr | ₹12.97 Cr | ₹14.68 Cr | ₹10.85 Cr | ₹27.59 Cr | ₹10.94 Cr |
| Profit Before Exceptional Items & Tax | ₹73.08 Lakh | ₹84.34 Lakh | ₹80.54 Lakh | ₹73.68 Lakh | ₹69.4 Lakh | ₹75.23 Lakh | ₹1.45 Cr | ₹68.4 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹73.08 Lakh | ₹84.34 Lakh | ₹80.54 Lakh | ₹73.68 Lakh | ₹69.4 Lakh | ₹75.23 Lakh | ₹1.45 Cr | ₹68.4 Lakh |
| Total Tax Expense | ₹30.67 Lakh | ₹23.19 Lakh | ₹21.35 Lakh | ₹18.08 Lakh | ₹16.09 Lakh | ₹20.57 Lakh | ₹45.64 Lakh | ₹18.69 Lakh |
| Net Profit | ₹42.41 Lakh | ₹61.15 Lakh | ₹59.19 Lakh | ₹55.6 Lakh | ₹53.31 Lakh | ₹54.66 Lakh | ₹98.89 Lakh | ₹49.71 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹42.41 Lakh | ₹61.15 Lakh | ₹59.19 Lakh | ₹55.6 Lakh | ₹53.31 Lakh | ₹54.66 Lakh | ₹98.89 Lakh | ₹49.71 Lakh |
| EBITDA (computed) | ₹1.29 Cr | ₹1.4 Cr | ₹1.44 Cr | ₹1.35 Cr | ₹1.13 Cr | ₹1.09 Cr | ₹1.77 Cr | ₹80.7 Lakh |
| Basic EPS | ₹0.42 | ₹0.61 | ₹0.59 | ₹0.56 | ₹0.53 | ₹0.55 | ₹0.99 | ₹0.50 |
| Diluted EPS | ₹0.42 | ₹0.61 | ₹0.59 | ₹0.56 | ₹0.53 | ₹0.55 | ₹0.99 | ₹0.50 |
Shareholding Pattern of Medico Intercontinental Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 57.15%, retail and other public shareholders hold 42.85% of Medico Intercontinental Limited. The company had 3,499 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 57.15% | 57.15% | 55.17% | 55.17% | 55.17% | 55.17% |
| Public | 42.85% | 42.85% | 44.83% | 44.83% | 44.83% | 44.83% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 57.15% | 55.17% | 55.08% |
| Public | 42.85% | 44.83% | 44.92% |
| Promoter change (YoY, %pts) | +1.98 | +0.09 | - |
Group Structure of Medico Intercontinental Limited
Medico Intercontinental Limited has 4 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Medico Intercontinental Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Sungrace Pharma Private Limited | U24110GJ2019PTC106267 | - |
| Azillian Healthcare Private Limited | U24230GJ2005PTC047259 | - |
| Ritz Formulations Private Limited | U24230GJ2019PTC106181 | - |
| Evagrace Pharma Private Limited | U51909GJ2018PTC105415 | - |
Showing major subsidiaries. Total: 4.
Charges & Borrowings of Medico Intercontinental Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 May 2019 | Standard Chartered Bank | ₹15.5 Cr | Open |
| 02 Mar 2021 | Others | ₹1.05 Cr | Satisfied |
| 06 Nov 2020 | Standard Chartered Bank | ₹1 Cr | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Medico Intercontinental Limited
Medico Intercontinental Limited has a workforce of 17 employees as of Sep 26, 2025.
Employee Count & EPFO Data of Medico Intercontinental Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Medico Intercontinental Limited
GSTIN & GST Filing Data of Medico Intercontinental Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Medico Intercontinental Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Medico Intercontinental Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Medico Intercontinental Limited
MSME Payment Delays by Medico Intercontinental Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Medico Intercontinental Limited
Subsidiaries & Group Companies of Medico Intercontinental Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Medico Intercontinental Limited with ownership details.
MCA Filings & Documents of Medico Intercontinental Limited
MCA Filings & Documents of Medico Intercontinental Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Medico Intercontinental Limited
Frequently Asked Questions about Medico Intercontinental Limited
Medico Intercontinental Limited is an active public limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 14 August 1984 (42+ years old) and is registered under CIN L24100GJ1984PLC111413. Listed on BSE: 539938. The company has 17 employees.
Medico Intercontinental Limited reported revenue of ₹96.37 Cr for FY 2025 (up 34.00% YoY).
The current directors of Medico Intercontinental Limited are:
- Samir Dilipkumar Shah
- Dilipkumar Shah Bhogilal
- Ankur Amiram Dave
- Swati Vikramkumar Shah
- Jay Sharadkumar Shah
- Puneeta Sharma
- Priyank Lalitbhai Sancheti
- Parshwa Kaushal Shah
- Tanvi Samirbhai Shah
- Dilipkumar Bhogilal Shah
The primary industry of Medico Intercontinental Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.
Yes. Medico Intercontinental Limited is listed on BSE with code 539938.
Medico Intercontinental Limited can be reached at the registered office: 1 – 5Th Floor Adit Raj Arcade Nr Karma Shreshtha Tower 100 Ft Rd Sat, Ellite, Ahmedabad, Gujarat, India – 380015, or through the website medicointercontinental.com.